Free Trial
OTCMKTS:TRUMY

Terumo Q1 2027 Earnings Results & Report

Terumo logo
$15.05 0.00 (0.00%)
As of 11/13/2026 03:55 PM Eastern

Terumo beat analyst expectations on both earnings and revenue in its Q1 2027 results, released August 7, 2026. The company reported EPS of $0.30 versus the $0.17 consensus estimate, while revenue of $1.97 billion topped the $1.84 billion estimate by $133.41 million.

Earnings Announcement Details

Quarter
Q1 2027
Report Date
Time
After Market Closes

Terumo EPS Results

Actual EPS
$0.30
Consensus EPS
$0.17
Beat/Miss
Beat by +$0.13
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

Terumo Revenue Results

Actual Revenue
$1.97 billion
Expected Revenue
$1.84 billion
Beat/Miss
Beat by +$133.41 million
YoY Revenue Growth
N/A

Conference Call Resources

Terumo Q1 2027 Earnings FAQ

Terumo (OTCMKTS:TRUMY) reported earnings of $0.30 per share for Q1 2027, beating the consensus estimate of $0.17. The report was announced on Friday, August 7, 2026.

Terumo reported revenue of $1.97 billion for Q1 2027, against a consensus estimate of $1.84 billion.

Terumo Earnings Headlines

Terumo (OTCMKTS:TRUMY) Shares Gap Down Following Weak Earnings
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
Terumo (OTCMKTS:TRUMY) Stock Falls 7.4% Following Weak Earnings
Terumo Corporation (TRUMY) Q2 2027 Earnings Call Transcript
Terumo ADR (TRUMY) Ratios
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services.

Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

Headquartered in Tokyo, Terumo serves healthcare customers in Japan and markets around the world. Its products support areas including patient care, cardiovascular treatment, transfusion medicine and cell therapy.

View Terumo Profile